Notable Labs (NASDAQ:NTBL – Get Free Report) was downgraded by equities research analysts at JMP Securities from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Friday, MarketBeat Ratings reports.
Notable Labs Stock Performance
Shares of NTBL opened at $0.45 on Friday. Notable Labs has a 12-month low of $0.40 and a 12-month high of $10.08. The business has a 50-day simple moving average of $0.56 and a two-hundred day simple moving average of $0.90. The company has a quick ratio of 2.77, a current ratio of 2.77 and a debt-to-equity ratio of 0.03.
Notable Labs (NASDAQ:NTBL – Get Free Report) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.55) earnings per share (EPS) for the quarter. As a group, analysts predict that Notable Labs will post -0.75 EPS for the current year.
About Notable Labs
Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment.
Featured Stories
- Five stocks we like better than Notable Labs
- Pros And Cons Of Monthly Dividend Stocks
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- 10 Best Airline Stocks to Buy
- MarketBeat Week in Review – 9/16 – 9/20
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Notable Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Notable Labs and related companies with MarketBeat.com's FREE daily email newsletter.
